{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:58Z","timestamp":1791357238062,"version":"4.3.1"},"reference-count":58,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T00:00:00Z","timestamp":1316995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p>\n            <jats:bold>Background:\u2002<\/jats:bold> Despite advances in developing medications to treat alcohol dependence, few such medications have been approved by the Food and Drug Administration. Identified molecular targets are encouraging and can lead to the development and testing of new compounds. Atypical antipsychotic medications have been explored with varying results. Prior research suggests that the antipsychotic quetiapine may be beneficial in an alcohol\u2010dependent population of very heavy drinkers.<\/jats:p><jats:p>\n            <jats:bold>Methods:\u2002<\/jats:bold> In this double\u2010blind, placebo\u2010controlled trial, 224 alcohol\u2010dependent patients who reported very heavy drinking were recruited across 5 clinical sites. Patients received either quetiapine or placebo and Medical Management behavioral intervention. Patients were stratified on gender, clinical site, and reduction in drinking prior to randomization.<\/jats:p><jats:p>\n            <jats:bold>Results:\u2002<\/jats:bold> No differences between the quetiapine and placebo groups were detected in the primary outcome, percentage heavy\u2010drinking days, or other drinking outcomes. Quetiapine significantly reduced depressive symptoms and improved sleep but had no effect on other nondrinking outcomes. Results from a subgroup analysis suggest that patients who reduced their drinking prior to randomization had significantly better drinking outcomes during the maintenance phase (<jats:italic>p<\/jats:italic>\u2003&lt;\u20030.0001). No significant interactions, however, were observed between reducer status and treatment group. Finally, quetiapine was generally well tolerated. Statistically significant adverse events that were more common with quetiapine versus placebo include dizziness (14 vs. 4%), dry mouth (32 vs. 9%), dyspepsia (13 vs. 2%), increased appetite (11 vs. 1%), sedation (15 vs. 3%), and somnolence (34 vs. 9%).<\/jats:p><jats:p>\n            <jats:bold>Conclusions:\u2002<\/jats:bold> This multisite clinical trial showed no efficacy for quetiapine compared with placebo at reducing alcohol consumption in heavy\u2010drinking alcohol\u2010dependent patients.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2011.01649.x","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T00:19:52Z","timestamp":1317169192000},"page":"406-416","source":"Crossref","is-referenced-by-count":87,"title":["A Double\u2010Blind, Placebo\u2010Controlled Trial to Assess the Efficacy of Quetiapine Fumarate XR in Very Heavy\u2010Drinking Alcohol\u2010Dependent Patients"],"prefix":"10.1111","volume":"36","author":[{"given":"Raye Z.","family":"Litten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne B.","family":"Fertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristin","family":"Murtaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenic","family":"Ciraulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan I.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bankole","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Pettinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Swift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Brunette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassima A.\u2010D.","family":"Tiouririne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the NCIG 001 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1992.tb00695.x"},{"key":"e_1_2_7_3_1","unstructured":"American Psychiatric Association(1994)Diagnostic and Statistical Manual of Mental Disorders Fourth Edition [DSM\u2010IV].American Psychiatric Publishing Inc. Washington DC."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e3181602fd4"},{"key":"e_1_2_7_5_1","doi-asserted-by":"crossref","unstructured":"AstraZeneca(2010)Investigator\u2019s Brochure: Quetiapine fumarate.AstraZeneca Wilmington DE.","DOI":"10.3833\/pdr.v2010i5.1345"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbl003"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2006.04.007"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1425"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033464"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/58.3.403"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.019"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2005.66.369"},{"key":"e_1_2_7_15_1","unstructured":"FirstM SpitzerRL GibbonM WilliamsJ(1996)Structured Clinical Interview for DSM\u2010IV Axis I Disorders Clinician Version (SCID\u2010CV).American Psychiatric Press Inc. Washington DC."},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04349.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1617"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000125352.06688.F7"},{"key":"e_1_2_7_19_1","first-page":"194","volume-title":"ECDEU Assessment Manual, 1976","author":"Guy W","year":"1976"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.58.2.175"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.1973.tb00801.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000629"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300917"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.08.005"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.14.1641"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2011.01523.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3180ca86e5"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn110"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050045"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.06.012"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","unstructured":"KoobG Le MoalM(2006).Neurobiology of Addiction.Elsevier Amsterdam.","DOI":"10.1016\/B978-012419239-3\/50043-6"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00608.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01170.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.10.2.323"},{"key":"e_1_2_7_36_1","first-page":"53","article-title":"Signal detection and placebo response in schizophrenia: parallels with depression","volume":"43","author":"Mallinckrodt C","year":"2010","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(85)90030-4"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ps.39.020188.001255"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.944"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108089596"},{"key":"e_1_2_7_41_1","first-page":"1","volume-title":"NIAAA Project MATCH Monograph Series","author":"Miller W","year":"1995"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb02627.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000138763.23482.2a"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_7_45_1","unstructured":"PettinatiH WeissR MillerW DonovanD ErnstD RounsavilleB(2004)Medical Management (MM) Treatment Manual.National Institute on Alcohol Abuse and Alcoholism Bethesda MD."},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.2307\/2529944"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.2307\/2529712"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00185.x"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60746-7"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169624.37819.60"},{"key":"e_1_2_7_51_1","first-page":"452","article-title":"Potential benefits of quetiapine in the treatment of substance dependence disorders","volume":"29","author":"Sattar S","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_7_53_1","unstructured":"SobellL AgrawlaS SobellM LeoG CunninghamJ YoungL(2003 November)Responding to an advertisement: a critical event in promoting self\u2010change of drinking behavior. Poster presented at the 37th Annual Meeting of the Association for the Advancement of Behavior Therapy Boston MA."},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0357-5_3"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsas.1994.s12.70"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00737.x"},{"key":"e_1_2_7_57_1","first-page":"355","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Szabo S","year":"1996"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2008.00783.x"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.14.1840"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2011.01649.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2011.01649.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:09:42Z","timestamp":1698786582000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2011.01649.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,26]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1111\/j.1530-0277.2011.01649.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2011.01649.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,26]]}}}